Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Gerlach

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Therapeutic Drug Monitoring|March 21, 2020
Dose-Related Concentrations of Neuroactive/Psychoactive Drugs Expected in Blood of Children and AdolescentsStefanie Fekete, Christoph Hiemke, Manfred Gerlach
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|June 15, 2006
[Therapy with lithium salts in child and adolescent psychiatry--clinical efficacy and practical recommendations]Manfred Gerlach, Lioba Baving, Joerg Fegert
Current Pharmaceutical Design|June 2, 2010
Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorderNathalie Bock, Manfred Gerlach, Aribert Rothenberger
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|December 15, 2017
[Does methylphenidate cause liver damage? An analysis of ad hoc reports to the "Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)"]Stefanie Fekete, Marcel Romanos, Manfred Gerlach
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 5, 2023
[Particularities and problems of psychopharmacology in childhood and adolescence]Manfred Gerlach, Tobias Renner, Marcel Romanos
Parkinsonism & Related Disorders|July 1, 2008
Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's diseaseManfred Gerlach, Peter Riederer, Kay L Double
Journal of Neural Transmission (Vienna, Austria : 1996)|September 14, 2012
Considerations for measuring iron in post-mortem tissue of Parkinson's disease patientsDominic J Hare, Manfred Gerlach, Peter Riederer
Attention Deficit and Hyperactivity Disorders|April 23, 2013
Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?Manfred Gerlach, Edna Grünblatt, Klaus W Lange
Parkinsonism & Related Disorders|October 9, 2007
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's diseasePeter Riederer, Manfred Gerlach, Thomas Müller, et al.
Journal of Epidemiology and Community Health|August 21, 2009
Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sampleMarcel Romanos, Manfred Gerlach, Andreas Warnke, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Therapeutic Drug Monitoring|March 21, 2020
Dose-Related Concentrations of Neuroactive/Psychoactive Drugs Expected in Blood of Children and AdolescentsStefanie Fekete, Christoph Hiemke, Manfred Gerlach
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|June 15, 2006
[Therapy with lithium salts in child and adolescent psychiatry--clinical efficacy and practical recommendations]Manfred Gerlach, Lioba Baving, Joerg Fegert
Current Pharmaceutical Design|June 2, 2010
Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorderNathalie Bock, Manfred Gerlach, Aribert Rothenberger
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|December 15, 2017
[Does methylphenidate cause liver damage? An analysis of ad hoc reports to the "Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)"]Stefanie Fekete, Marcel Romanos, Manfred Gerlach
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 5, 2023
[Particularities and problems of psychopharmacology in childhood and adolescence]Manfred Gerlach, Tobias Renner, Marcel Romanos
Parkinsonism & Related Disorders|July 1, 2008
Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's diseaseManfred Gerlach, Peter Riederer, Kay L Double
Journal of Neural Transmission (Vienna, Austria : 1996)|September 14, 2012
Considerations for measuring iron in post-mortem tissue of Parkinson's disease patientsDominic J Hare, Manfred Gerlach, Peter Riederer
Attention Deficit and Hyperactivity Disorders|April 23, 2013
Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?Manfred Gerlach, Edna Grünblatt, Klaus W Lange
Parkinsonism & Related Disorders|October 9, 2007
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's diseasePeter Riederer, Manfred Gerlach, Thomas Müller, et al.
Journal of Epidemiology and Community Health|August 21, 2009
Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sampleMarcel Romanos, Manfred Gerlach, Andreas Warnke, et al.
Pageof 15